Sign in to view content

Safety of Intravitreal Pegcetacoplan in Geographic Atrophy: Results from the Phase 3 DERBY and OAKS Trials

David S. Boyer, MD

Video
Published 2021

Related

Evaluating ANX007, a Novel C1q Inhibitor, in the Treatment of Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration: The ARCHER Study
Nancy M. Holekamp, MD, FASRS
Annual Meeting Talks
2021
Vitreoretinal Interface Disease In the Setting of AMD
Andrew A. Moshfeghi, MD, MBA, FASRS
Updates from the Field
2019
Histologic Correlates for OCT Signatures Occurring in AMD
K. Bailey Freund, MD
Updates from the Field
2020

Category: AMD-Non-neovascular

See more